z-logo
open-access-imgOpen Access
Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
Author(s) -
Pathum Sookaromdee,
Viroj Wiwanitkit
Publication year - 2021
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_308_21
Subject(s) - hyperviscosity , medicine , blood viscosity , vaccination , covid-19 , hyperviscosity syndrome , diabetes mellitus , thrombosis , cardiology , disease , immunology , endocrinology , infectious disease (medical specialty) , multiple myeloma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here